FeesSafety
Pluang+

M-tron CEO and VP to meet investors at Sonoma Small Cap Symposium on Nov 16, 2026.

Market News
03 Nov 2026, 15:55 WIB
PRNewsWire
View Source
Neutral
M-tron CEO and VP to meet investors at Sonoma Small Cap Symposium on Nov 16, 2026.

M-tron Industries announced that CEO Cameron Pforr and VP of Financial Reporting Chris Nossokoff will hold one-on-one meetings with investors at the Raymond James Sonoma Small Cap Symposium on November 16, 2026. This event provides an opportunity for institutional investors to engage directly with M-tron's management and learn more about the company's operations and future plans. M-tron specializes in high-reliability frequency and spectrum control products for aerospace and defense sectors, with facilities in the US, Hong Kong, and India. The meetings could help boost investor confidence and visibility ahead of future developments.

M-tron Industries' upcoming investor meetings coincide with a day where 75 of 135 Industrials-sector US stocks on Pluang rose as of Nov 03, 2026 20:11 WIB. For readers following Industrials, here is Pluang's market snapshot: TRMD (TORM plc) led with a price of USD 41.50 and a 4.22% increase, supported by 100% buy order activity and a typical hold time of 25 days. Meanwhile, LUNR (Intuitive Machines) and AMSC (American Superconductor Corporation) saw price gains of 3.45% and 3.11% respectively, though both had 100% sell order activity on Pluang.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App